Foreverland Food | $6,956,279 | (Mar 24, 2026)
Meadow Memorials | $9,000,000 | (Mar 24, 2026)
Oryon Cell Therapies | $21,000,000 | (Mar 24, 2026)
Avenda Health
United States
- Culver City, California
- 30/08/2022
- Series B
- $10,000,000
1 in 7 men will be diagnosed with prostate cancer in their lifetime, and the current standard of care in treatment significantly impairs quality of life due to imprecision.
Avenda Health is creating a more personalized future of prostate cancer care. We've built a platform that uses deep learning to map a patient's cancer in 3D, giving physicians precise information and the confidence to make care decisions. This is paired with a proprietary targeted ablative therapy that can treat patients in a doctors office under local anesthesia. Avenda Health aims to improve outcomes, preserve quality of life, and create a new standard of cancer care.
- Industry Medical Equipment Manufacturing
- Website https://avendahealth.com/
- LinkedIn https://www.linkedin.com/company/avenda-health/
Related People
Shyam NatarajanCo Founder
United States -
Los Angeles, California
Focused on improving clinical outcomes and patient care in urology and beyond.
Leading a clinical-stage AI healthcare startup that is creating a more personalized future of prostate cancer care. Previously led an NIH-funded lab focusing on image-guided cancer interventions at UCLA with a background in software engineering.
Hamilton AI | $7,500,000 | (Mar 24, 2026)
Flourish Care | $5,700,000 | (Mar 24, 2026)
Interloom | $16,500,000 | (Mar 24, 2026)
eternal.ag | $9,271,160 | (Mar 24, 2026)
EGIDE | $9,266,200 | (Mar 24, 2026)
Cleavr | $1,158,600 | (Mar 24, 2026)
SPARK Microsystems | $12,364,525 | (Mar 24, 2026)
JAAQ | $17,416,100 | (Mar 24, 2026)
CisLunar Industries | $2,600,000 | (Mar 24, 2026)